Press release
Revolutionizing Pharma: New Blockchain-Based Supply Chain Launched
The pharmaceutical supply chain industry size was valued at $66 billion in 2021, and is estimated to reach $106.8 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.There are prominent key factors that drive the growth of the pharmaceutical supply chain market, such as growth in pharmaceutical sector, increase in international trade activities, and increase in demand for reverse logistics in pharmaceutical sector. The global logistics have experienced tremendous transformation in the past few years. Owing to the COVID-19 pandemic, the shippers are focusing on using faster and cost-effective method of shipping the cargo, which is expected to fuel the market for pharmaceutical supply chain. Moreover, numerous healthcare service providing companies are focusing on expansion of their refrigerated warehouse capacity, which in turn contributes in the growth of the pharmaceutical supply chain industry.
Buy This Premium Research Report- https://www.alliedmarketresearch.com/pharmaceutical-logistics-market/purchase-options
In 2021, Asia-Pacific region is dominating the market in terms of revenue, followed by North America, Europe, and LAMEA. U.S. and China dominated the pharmaceutical supply chain market during the forecast period. Increased adoption of outsourced logistics services in the region is driving the growth of the market in Asia-Pacific. Moreover, high government support for development of logistics infrastructure in the region is also boosting the market growth.
The pharmaceutical supply chain market is segmented on the basis of operation, business type, application, type and region. By operation, it is divided into seaways, roadways, railways, airways, and storage & services. By business type, it is divided into transportation, warehousing, and value-added services. By application, it is segmented into bio pharma, chemical pharma, and specialty pharma. By type, it is divided into cold chain, and non-cold chain. By region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.
Request Research Sample with Industry Insights @ https://www.alliedmarketresearch.com/request-sample/14871
Segmentation Based on:
By Business Type:
Transportation
Warehousing
Value added Services
By Application:
Bio Pharma
Chemical Pharma
Speciality Pharma
By Type:
Non Cold Chain
Cold Chain
By Operation:
Seaways
Roadways
Railways
Airways
Storage and Services
Top Companies:
The key players that operate in this pharmaceutical supply chain market are Agility, Ceva Logistics, CJ Century Logistics, CWT Ltd, DB Schenker, DHL Supply Chain, Gemadept, Keppel Logistics, Kerry Logistics, Kuehne + Nagel, Singapore Post, Tiong Nam Logistics, WHA Corp., Ych Group and Yusen Logistics.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14871
ππ¨π§ππππ:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Revolutionizing Pharma: New Blockchain-Based Supply Chain Launched here
News-ID: 3254909 • Views: β¦
More Releases from Allied Analytics LLP
Human Capital Management Market Growth Driven by AI and Cloud-Based HR Solutions
According to a new report published by Allied Market Research, the human capital management market size was valued at $21.8 billion in 2021 and is estimated to reach $51.3 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. The increasing adoption of cloud-based HR solutions, rising automation of workforce management processes, and growing demand for unified employee management platforms are major factors driving the growth ofβ¦
Fitness App Industry Witnesses Rapid Growth with Rising Health Awareness Worldwi β¦
According to a recent report published by Allied Market Research, the global fitness app market size was valued at $13.78 billion in 2020 and is projected to reach $120.37 billion by 2030, growing at a CAGR of 24.3% from 2021 to 2030. The growing focus on personal health, increasing adoption of smartphones and wearable devices, and rising awareness regarding preventive healthcare are significantly driving the expansion of the fitness appβ¦
E-Learning Industry to Witness Strong Growth with AI and Cloud-Based Platforms
According to a new report published by Allied Market Research, the global E-learning market size was valued at $263.5 billion in 2023 and is projected to reach $933.5 billion by 2032, growing at a CAGR of 14.8% from 2024 to 2032. The rapid adoption of digital learning platforms, increased internet penetration, and growing demand for flexible education models are major factors driving the expansion of the e-learning market worldwide.
Download PDFβ¦
Global Building Information Modeling Industry Forecast and Future Opportunities β¦
According to a new report published by Allied Market Research, the building information modeling market size was valued at $7.9 billion in 2022 and is estimated to reach $34.2 billion by 2032, growing at a CAGR of 16% from 2023 to 2032.
The rapid digital transformation of the global construction industry is significantly boosting the adoption of advanced technologies such as Building Information Modeling (BIM). As governments, contractors, architects, and engineeringβ¦
More Releases for Pharma
Schizophrenia Market Forecast 2036: Rising Demand, Novel Therapies, and Commerci β¦
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, Minerva Neurosciences, Karuna Therapeutics, Acadia Pharmaceuticals, Boehringer Ingelheim, Otsuka Pharmaceutical, Lyndra Therapeutics, Neurocrine Biosciences, and others.
(Albany, New York) - October 19, 2026: DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysisβ¦
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten β¦
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailedβ¦
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva β¦
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asβ¦
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh β¦
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theβ¦
